Tobacco smoking during radiation therapy for head-and-neck cancer is associated with unfavorable outcome

Allen M. Chen, Leon M. Chen, Andrew T M Vaughan, Radhika Sreeraman, D Gregory Farwell, Quang Luu, Derick H Lau, Kerri Stuart, James A. Purdy, Srinivasan Vijayakumar

Research output: Contribution to journalArticle

108 Citations (Scopus)

Abstract

Purpose: To evaluate the effect of continued cigarette smoking among patients undergoing radiation therapy for head-and-neck cancer by comparing the clinical outcomes among active smokers and quitters. Methods and Materials: A review of medical records identified 101 patients with newly diagnosed squamous cell carcinoma of the head and neck who continued to smoke during radiation therapy. Each active smoker was matched to a control patient who had quit smoking before initiation of radiation therapy. Matching was based on tobacco history (pack-years), primary site, age, sex, Karnofsky Performance Status, disease stage, radiation dose, chemotherapy use, year of treatment, and whether surgical resection was performed. Outcomes were compared by use of Kaplan-Meier analysis. Normal tissue effects were graded according to the Radiation Therapy Oncology Group/European Organization for the Treatment of Cancer toxicity criteria. Results: With a median follow-up of 49 months, active smokers had significantly inferior 5-year overall survival (23% vs. 55%), locoregional control (58% vs. 69%), and disease-free survival (42% vs. 65%) compared with the former smokers who had quit before radiation therapy (p < 0.05 for all). These differences remained statistically significant when patients treated by postoperative or definitive radiation therapy were analyzed separately. The incidence of Grade 3 or greater late complications was also significantly increased among active smokers compared with former smokers (49% vs. 31%, p = 0.01). Conclusions: Tobacco smoking during radiation therapy for head-and-neck cancer is associated with unfavorable outcomes. Further studies analyzing the biologic and molecular reasons underlying these differences are planned.

Original languageEnglish (US)
Pages (from-to)414-419
Number of pages6
JournalInternational Journal of Radiation Oncology Biology Physics
Volume79
Issue number2
DOIs
StatePublished - Feb 1 2011

Fingerprint

tobacco
Head and Neck Neoplasms
radiation therapy
Radiotherapy
Smoking
cancer
Karnofsky Performance Status
Radiation Oncology
smoke
Kaplan-Meier Estimate
chemotherapy
Smoke
toxicity
Disease-Free Survival
Tobacco
Medical Records
grade
incidence
History
histories

Keywords

  • Head-and-neck cancer
  • Radiation therapy
  • Smoking
  • Tobacco

ASJC Scopus subject areas

  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Radiation
  • Cancer Research

Cite this

Tobacco smoking during radiation therapy for head-and-neck cancer is associated with unfavorable outcome. / Chen, Allen M.; Chen, Leon M.; Vaughan, Andrew T M; Sreeraman, Radhika; Farwell, D Gregory; Luu, Quang; Lau, Derick H; Stuart, Kerri; Purdy, James A.; Vijayakumar, Srinivasan.

In: International Journal of Radiation Oncology Biology Physics, Vol. 79, No. 2, 01.02.2011, p. 414-419.

Research output: Contribution to journalArticle

Chen, Allen M. ; Chen, Leon M. ; Vaughan, Andrew T M ; Sreeraman, Radhika ; Farwell, D Gregory ; Luu, Quang ; Lau, Derick H ; Stuart, Kerri ; Purdy, James A. ; Vijayakumar, Srinivasan. / Tobacco smoking during radiation therapy for head-and-neck cancer is associated with unfavorable outcome. In: International Journal of Radiation Oncology Biology Physics. 2011 ; Vol. 79, No. 2. pp. 414-419.
@article{0d4eca930b424f088f8503bd7eb1e5cf,
title = "Tobacco smoking during radiation therapy for head-and-neck cancer is associated with unfavorable outcome",
abstract = "Purpose: To evaluate the effect of continued cigarette smoking among patients undergoing radiation therapy for head-and-neck cancer by comparing the clinical outcomes among active smokers and quitters. Methods and Materials: A review of medical records identified 101 patients with newly diagnosed squamous cell carcinoma of the head and neck who continued to smoke during radiation therapy. Each active smoker was matched to a control patient who had quit smoking before initiation of radiation therapy. Matching was based on tobacco history (pack-years), primary site, age, sex, Karnofsky Performance Status, disease stage, radiation dose, chemotherapy use, year of treatment, and whether surgical resection was performed. Outcomes were compared by use of Kaplan-Meier analysis. Normal tissue effects were graded according to the Radiation Therapy Oncology Group/European Organization for the Treatment of Cancer toxicity criteria. Results: With a median follow-up of 49 months, active smokers had significantly inferior 5-year overall survival (23{\%} vs. 55{\%}), locoregional control (58{\%} vs. 69{\%}), and disease-free survival (42{\%} vs. 65{\%}) compared with the former smokers who had quit before radiation therapy (p < 0.05 for all). These differences remained statistically significant when patients treated by postoperative or definitive radiation therapy were analyzed separately. The incidence of Grade 3 or greater late complications was also significantly increased among active smokers compared with former smokers (49{\%} vs. 31{\%}, p = 0.01). Conclusions: Tobacco smoking during radiation therapy for head-and-neck cancer is associated with unfavorable outcomes. Further studies analyzing the biologic and molecular reasons underlying these differences are planned.",
keywords = "Head-and-neck cancer, Radiation therapy, Smoking, Tobacco",
author = "Chen, {Allen M.} and Chen, {Leon M.} and Vaughan, {Andrew T M} and Radhika Sreeraman and Farwell, {D Gregory} and Quang Luu and Lau, {Derick H} and Kerri Stuart and Purdy, {James A.} and Srinivasan Vijayakumar",
year = "2011",
month = "2",
day = "1",
doi = "10.1016/j.ijrobp.2009.10.050",
language = "English (US)",
volume = "79",
pages = "414--419",
journal = "International Journal of Radiation Oncology Biology Physics",
issn = "0360-3016",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - Tobacco smoking during radiation therapy for head-and-neck cancer is associated with unfavorable outcome

AU - Chen, Allen M.

AU - Chen, Leon M.

AU - Vaughan, Andrew T M

AU - Sreeraman, Radhika

AU - Farwell, D Gregory

AU - Luu, Quang

AU - Lau, Derick H

AU - Stuart, Kerri

AU - Purdy, James A.

AU - Vijayakumar, Srinivasan

PY - 2011/2/1

Y1 - 2011/2/1

N2 - Purpose: To evaluate the effect of continued cigarette smoking among patients undergoing radiation therapy for head-and-neck cancer by comparing the clinical outcomes among active smokers and quitters. Methods and Materials: A review of medical records identified 101 patients with newly diagnosed squamous cell carcinoma of the head and neck who continued to smoke during radiation therapy. Each active smoker was matched to a control patient who had quit smoking before initiation of radiation therapy. Matching was based on tobacco history (pack-years), primary site, age, sex, Karnofsky Performance Status, disease stage, radiation dose, chemotherapy use, year of treatment, and whether surgical resection was performed. Outcomes were compared by use of Kaplan-Meier analysis. Normal tissue effects were graded according to the Radiation Therapy Oncology Group/European Organization for the Treatment of Cancer toxicity criteria. Results: With a median follow-up of 49 months, active smokers had significantly inferior 5-year overall survival (23% vs. 55%), locoregional control (58% vs. 69%), and disease-free survival (42% vs. 65%) compared with the former smokers who had quit before radiation therapy (p < 0.05 for all). These differences remained statistically significant when patients treated by postoperative or definitive radiation therapy were analyzed separately. The incidence of Grade 3 or greater late complications was also significantly increased among active smokers compared with former smokers (49% vs. 31%, p = 0.01). Conclusions: Tobacco smoking during radiation therapy for head-and-neck cancer is associated with unfavorable outcomes. Further studies analyzing the biologic and molecular reasons underlying these differences are planned.

AB - Purpose: To evaluate the effect of continued cigarette smoking among patients undergoing radiation therapy for head-and-neck cancer by comparing the clinical outcomes among active smokers and quitters. Methods and Materials: A review of medical records identified 101 patients with newly diagnosed squamous cell carcinoma of the head and neck who continued to smoke during radiation therapy. Each active smoker was matched to a control patient who had quit smoking before initiation of radiation therapy. Matching was based on tobacco history (pack-years), primary site, age, sex, Karnofsky Performance Status, disease stage, radiation dose, chemotherapy use, year of treatment, and whether surgical resection was performed. Outcomes were compared by use of Kaplan-Meier analysis. Normal tissue effects were graded according to the Radiation Therapy Oncology Group/European Organization for the Treatment of Cancer toxicity criteria. Results: With a median follow-up of 49 months, active smokers had significantly inferior 5-year overall survival (23% vs. 55%), locoregional control (58% vs. 69%), and disease-free survival (42% vs. 65%) compared with the former smokers who had quit before radiation therapy (p < 0.05 for all). These differences remained statistically significant when patients treated by postoperative or definitive radiation therapy were analyzed separately. The incidence of Grade 3 or greater late complications was also significantly increased among active smokers compared with former smokers (49% vs. 31%, p = 0.01). Conclusions: Tobacco smoking during radiation therapy for head-and-neck cancer is associated with unfavorable outcomes. Further studies analyzing the biologic and molecular reasons underlying these differences are planned.

KW - Head-and-neck cancer

KW - Radiation therapy

KW - Smoking

KW - Tobacco

UR - http://www.scopus.com/inward/record.url?scp=78650820605&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78650820605&partnerID=8YFLogxK

U2 - 10.1016/j.ijrobp.2009.10.050

DO - 10.1016/j.ijrobp.2009.10.050

M3 - Article

C2 - 20399030

AN - SCOPUS:78650820605

VL - 79

SP - 414

EP - 419

JO - International Journal of Radiation Oncology Biology Physics

JF - International Journal of Radiation Oncology Biology Physics

SN - 0360-3016

IS - 2

ER -